Table 4.

Therapies and outcomes in pre-Covid seasons and 2020/2021 season.

	Pre-covid-19 seasons (n = 162)	Covid-19 season (n = 16)
	n (%)	n (%)	P value
Antibiotics use	102 (63)	10 (62)	0.97
Antiviral use	16 (10)	2 (12)	0.67
Oxygen therapy	135 (83)	7 (44)	0.046
CPAP	35 (22)	1 (6)	0.2
HFNC	88 (54)	6 (37)	0.2
Salbutamol aerosol	145 (89)	12 (75)	0.1
Mechanical ventilation	7 (4)	0 (0)	1
Hospitalization days, median (IQR)	6 (5–8)	4 (4–6)	0.006

CPAP, continuous positive airway pressure; HFNC, high-flow nasal cannula.